According to Novartis latest financial reports the total liabilities of NOVN is $53.20B, an decrease of -8.33% to 2022. At the end of 2022 company had $58.03B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Novartis is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $53.20B | -8.33% |
2022 | $58.03B | -9.29% |
2021 | $63.97B | -10.04% |
2020 | $71.11B | 13.20% |
2019 | $62.82B | 58.32% |
2018 | $39.68B | - |